Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Research & Discovery » Proteomics & Protein Research » Greg Lucier, David Hoffmeister, Ronald Matricaria, Per Peterson, Kelli Richard, Mike Gresser

Greg Lucier, David Hoffmeister, Ronald Matricaria, Per Peterson, Kelli Richard, Mike Gresser

Mar 08, 2007
Premium
Invitrogen’s $5M Man
 
Invitrogen CEO and chairman, Greg Lucier, made more than $5.4 million in 2006, according to the company’s proxy statement.
 
His base salary was $904,615, with the balance of his income coming from stock options, incentive payouts, and other compensation. David Hoffmeister, senior vice president and CFO, was the next highest paid executive at the company, pulling in $2.6 million.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Earlier in the US

An analysis of blood donations suggests SARS-CoV-2 was present in the US weeks earlier than thought, according to NPR.

How the Proteins Shape Up

The Guardian reports that DeepMind Technologies' AlphaFold can predict how proteins fold.

Who's to Be First?

CNBC reports that a US Centers for Disease Control and Prevention advisory panel is to vote on how to distribute COVID-19 vaccines.

PNAS Papers on Ovarian Cancer, Retrotransposon Insertions in Cancer, Malaria Mosquitoes

In PNAS this week: targeting progesterone signaling in ovarian cancer, LINE-1 retrotransposition events in adenocarcinomas, and more.

What's Popular?

In Proteomics & Protein Research

  1. Newomics Closes $7.9M Series B Funding Round

  2. UW-Madison Team Devises Workflow For LC-Free Proteomics

    Premium

  3. Mini Mass Spec Firm 908 Devices Files for IPO

  4. Somalogic Closes $121M Series A Funding

  5. Pediatric Brain Tumor Proteomics Highlight Possible Treatment Targets, Biomarkers

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.